Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
(Image credit: Fred Tanneau)
admin, , TECHNOLOGY, 0
Related Articles
Foreign nationals propel U.S. science. Visa limits under Trump could change that
The incoming Trump administration is likely to crack down on the H-1B visas used by tech companies and research...
New technology shows how illegal fishing has impacted oceans across the world
Illegal fishing has plagued oceans worldwide, and new technology is providing a view of its extent. New studies show...
Privacy advocates call on Maryland to investigate data brokers
Maryland has one of the strictest data privacy laws in the country. But privacy advocates allege that data brokers...
More than 50 House Democrats demand answers after whistleblower report on DOGE
Members of the Congressional Labor Caucus wrote the letter after NPR reported that a whistleblower says DOGE may have...
Tennessee teens sue Elon Musk’s xAI over AI-generated child sexual abuse material
The three girls say that the nonconsensual nude images were created by a perpetrator who used AI company xAI’s...
TikTok returns to the campaign trail but not everyone thinks it’s a good idea
As another major election inches closer, Democrats are navigating how TikTok fits into their 2024 campaign strategy, as the...
